Engineering IGF2 for Lysosome-targeting chimeras development to target drug-resistant membrane proteins in tumor therapy.
工程改造 IGF2 以开发溶酶体靶向嵌合体，从而靶向肿瘤治疗中的耐药膜蛋白
期刊:Protein Science
影响因子:5.2
doi:10.1002/pro.70051
Pan Yanchao, Xiang Qing, Deng Kai, Anwar Muhammad I, Wang Leiming, Wang Yuan, Liang Qiulian, Shen Lirou, Yang Jing, Hou Zhongyu, Shen Weijun
